Investorideas.com - Cannabis Deal Tracker
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Thursday, 17 October 2019
Investorideas.com - Cannabis Stock News: Neptune (NASDAQ: NEPT) (TSX: NEPT) Signs an Extraction Agreement in the U.S. and Expands U.S. Sales Team
Investorideas.com - Cannabis Stock News: Neptune (NASDAQ: NEPT) (TSX: NEPT) Signs an Extraction Agreement in the U.S. and Expands U.S. Sales Team
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Cannabis Stock News: HEXO (TSX: $HEXO.TO) (NYSE: $HEXO) launches cannabis value brand, Original Stash, with 1 oz product at $4.49 a gram including taxes
Investorideas.com - Cannabis Stock News: HEXO (TSX: $HEXO.TO) (NYSE: $HEXO) launches cannabis value brand, Original Stash, with 1 oz product at $4.49 a gram including taxes
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: Happy 1 Year Anniversary Canada! (NYSE: $ACB) (TSXV: $GYSR.V) (CSE: $BOSS.C) (TSXV: $NRTH.V) (NASDAQ: $NEPT) (CSE: $SOL.C) (NEO: CCHW)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move:
Happy 1 Year Anniversary Canada! (NYSE: $ACB) (TSXV: $GYSR.V)
(CSE: $BOSS.C)
(TSXV: $NRTH.V)
(NASDAQ: $NEPT)
(CSE: $SOL.C) (NEO: CCHW)
Delta, Kelowna, BC –October 17, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/10171ACB-GYSR-BOSS-NRTH-NEPT-SOL-CCHW.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In today’s
podcast we look today’s early announcements.
Aurora Cannabis
Inc. (NYSE: ACB) (TSX: ACB) announced its plans for the roll-out of
vapes, concentrates, and edibles when they are permitted for sale to consumers
in December. The Company has prioritized its resources to prepare for a
successful initial launch that will support an ongoing replenishment strategy
to help ensure consumers across Canada will have access to a diverse portfolio
of high-quality derivative products they want to buy.
You
can watch a compilation of our commercial production of vapes, mints,
chocolates and gummies HERE.
Photos
are available on Aurora's Investor website HERE.
"Aurora's
Product Development and Insights teams have done tremendous work to formulate
new products in a variety of formats that we think will exceed consumer
expectations and drive category growth," said Aurora CEO Terry Booth.
"Aurora has built industry-leading cannabis capacity and scalability
supported by our consumer research and retail distribution bench strength to
launch this next generation of cannabis products into the Canadian market. We
are ready to ship product as soon as the regulations allow and are excited for
consumers and patients to finally have access to a greater selection of product
forms. We are already working on expanding the range of new products beyond
those that will initially launch."
To
support the successful launch of vapes, concentrates, and edibles products, and
to continue to ensure sufficient supply for domestic and international markets,
Aurora has established production hubs in Eastern and Western Canada at Aurora
River (Bradford, Ontario), Aurora Vie (Pointe Claire, Quebec) and at Aurora Sky
(Leduc, Alberta).
These
centres are intended to provide centralized production, packaging, logistics
and distribution capabilities. In total, they comprise more than 450,000 square
feet and are strategically located to efficiently distribute Aurora's products
to markets across the country. In addition, Aurora Air, a 20,000 square foot
manufacturing facility near Aurora Sky at the Edmonton International Airport,
will be home to several of the new production lines for edible products.
Aurora's next generation products have been formulated to meet or exceed all
regulatory requirements. All new cannabis product forms are subject to a
legislated Health Canada 60-day review period that begins on October 17, 2019.
Geyser Brands Inc.
(formerly Kanzen Capital Corp.) (TSX-V: GYSR) announced that its subsidiary, 0957102 B.C.
Ltd. DBA Apothecary Botanicals, is preparing to commence its co-packing and
manufacturing operations as a means to grow Geyser Brands' in-house brands, as
well as bolster its operations by partnering with third-party consumer-packaged
goods brands, to bring cannabis to the mainstream in the health and wellness
sector.
Apothecary
Botanicals has signed a non-binding letter of intent to enter into a co-packing
agreement between Geyser Brands' subsidiary, Apothecary Botanicals, and The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), for the production and launch of
Yield Growth's Canadian cannabis brand 'Jack n Jane', a line of
cannabis-infused products including tinctures, topicals, and capsules.
Apothecary
Botanicals has been engaged to manufacture and distribute Yield Growth's 'Jack
n Jane' products, combining Yield Growth's proprietary formulations with
Apothecary Botanical's cannabis supply, services, facilities, equipment, and
required Health Canada licenses for processing and sales. Yield Growth will
supply all non-cannabis ingredients, packaging, and design while Apothecary
Botanicals will supply cannabis containing THC and/or CBD as required for the
various product formulations. The first phase of production is expected to
include three tinctures containing THC and CBD, with a goal of coming to market
by December 31, 2019.
Apothecary
Botanicals CEO, David Eto, commented, "I'm very pleased that Apothecary
Botanicals can leverage its manufacturing, formulation, and distribution
capabilities to assist Yield Growth expand into the Canadian market. Our
in-house expertise in the food & beverage sector will add tremendous value
to cannabis brands entering the Edibles market worth an estimated C$2.7 billion
annually in Canada alone. Our facilities are GMP-compliant and managed by food
sector specialists who understand the importance of food safety and quality.
Our business principles are grounded in building a transparent, cost effective,
and trusting partnership that will create long lasting business relationships
and positive experiences for customers who will consume edibles."
Geyser
Brands CEO, Andreas Thatcher, commented, "The goal of Apothecary
Botanicals is to deliver innovative formulations and high-quality manufacturing
using cannabis as an ingredient. This LOI shows that we are delivering on both.
As the new cannabis legislation comes into force, we are scaling our licensed
production into beverages, edibles and cosmetics. Our experience in food and
beverage, cosmetics, and GMP manufacturing provides a complete platform for
brands to enter the Canadian cannabis market."
48North Cannabis
Corp. (TSXV:NRTH) announced that it has signed an exclusive
licensing agreement with U.S.-based APCNA Holdings LLC.
("Apothecanna"), to bring its best-selling, premium cannabis topicals
brand to Canadian consumers.
Apothecanna,
an established U.S cannabis brand focused on organic topical formulations, made
without the use of artificial ingredients, fillers, parabens, or GMO
ingredients, has been a leading topicals brand in the United States since its
founding in 2009. Apothecanna has developed a suite of next-generation health
and wellness cannabis products including, but not limited to: pain relief
creams, a skincare line, sex oils, and other therapeutic cannabis-based
topicals.
48North
is focused on delivering best-in-class and innovative next-generation cannabis
products to Canadian consumers. To that end, the Company strongly believes that
value-added cannabis products that have succeeded in mature U.S markets, will
also succeed in the Canadian marketplace. The agreement with Apothecanna, on
the heels of the Company's previously announced licensing agreements with
Avitas and Mother & Clone, builds on 48North's growing portfolio of popular
U.S-based cannabis brands.
"Without
question, Apothecanna is one of the leading topical cannabis brands in the
United States. Since 2009, Apothecanna has led the charge in combating cannabis
stigma through spreading the wisdom of traditional plant medicine. They have
successfully formulated a suite of best-in-class health and wellness products
and developed an industry-leading brand. We are so excited to announce that
Apothecanna's products will soon be available for Canadian consumers,"
said Alison Gordon, CEO of 48North.
"Great
partnerships require shared values, and, like us, 48North is all about
innovation and performance. Their commitment to sustainability and all-natural
ingredients gave us the confidence we needed to expand our business into
Canada. We look forward to combining our formulations and expertise with
48North's high-quality outdoor cannabis with the vision of normalizing cannabis
through sport with the help of Good:Farm and 48North," said James Kennedy,
Founder and CEO, of Apothecanna.
Under
the terms of the licensing agreement signed October 16, 2019, 48North will
license Apothecanna intellectual property and manufacturing techniques for
domestic consumption in Canada.
Neptune Wellness
Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) announced that it entered into an agreement to
provide extraction services to a large U.S.-based farming services operation.
Under the contract terms, Neptune will receive hemp biomass to be processed and
transformed into crude oil extracts. The 2-year agreement could reach a total
value in excess of US$20 million. The first shipment of biomass is expected to
arrive at Neptune's North Carolina facility in the coming weeks.
"This
large contract will support our capacity expansion at our North Carolina
facility and better position us to serve the growing United States market. Our
expansion in North Carolina is on time and on budget with extraction capacity expected
to reach an annual run-rate of 1,500,000 kg of biomass by December 2019. Demand
for extraction and formulation services in the U.S. is currently strong with
the ongoing harvest season and our tolling and formulation pipeline to deliver
high quality full and broad spectrum extracts remains robust. This announcement
represents a further step towards our customer and geographic diversification
strategy," said Michael Cammarata, Neptune's CEO.
Neptune
also recently appointed Brett DuBose as Vice-President of Sales for the U.S.
Region. Brett has more than 20 years of sales experience, most recently with
Lonza Consumer Health and Nutrition where he was Associate Director Sales, for
the Eastern U.S and Canada. He has also worked for 14 years at Pfizer in the
Capsugel division, his last role being a Sales Manager Generic & Dietary
Supplement. "With his extensive industry contacts and experience, Brett
will play a key role in helping Neptune accelerate its market penetration in
the U.S.," said Mr. Cammarata.
Once
Neptune's near-term capacity expansion plans are complete and the Canadian
expansion approved by Health Canada, the Company is expected to have a total
extraction capacity of 3,000,000 kg of biomass annually, spread equally between
Canada and the U.S.
SOL Global
Investments Corp. (CSE: SOL) (OTC: SOLCF) announced that 3 Boys Farms, LLC , which owns
and operates one of the original fourteen (14) medical marijuana treatment
center licenses in Florida, will now operate under the business name "One Plant" after receiving the
required regulatory approvals. SOL Global embraced the name One Plant for 3
Boys Farm and the Company's proposed dispensaries nationwide as the team firmly
believes that just this "one" plant can solve countless problems.
Chief Executive Officer Brady Cobb said "this One Plant can provide relief
to patients suffering from so many debilitating conditions and illnesses and
can help patients avoid dangerously addictive opioids, and this One Plant can
also enhance and enrich patient's lives by giving them the freedom to enjoy
daily life in a meaningful way." The name change comes as SOL Global
accelerates its transition to a cannabis multi-state operator.
Additionally,
One Plant is proud to announce that its proprietary delivery model, which
launched in early July 2019, has shown tremendously positive results. From the
launch in early July through October 3, 2019, One Plant, known for its best in
class cannabis flower which is organically grown, has seen continued week over
week delivery growth of 20% or more, week over week patient onboarding of 20%
or more, and over a 300% increase in call volumes and orders from patients in
Florida. During the week of October 4-10, 20191, One Plant's sales
accelerated once it harvested and cured its first harvest after the previously
announced operational upgrades were implemented at its Ruskin, Florida
greenhouse facility. This harvest, which included One Plant's Ebony & Ivory
strain which test results confirmed had a market leading THC content of 27%,
resulted in One Plant sales increasing 140% week over week as compared to the
previous reporting period. One Plant rose to 7th (out of 14 MMTC's)
in flower sales in Florida, and 10th in overall sales in Florida,
respectively1. What is more impressive is that One Plant achieved
this increased sales volume all via its proprietary home delivery system, and
without having a single dispensing location open.
"The
fact we outsold our competitors, several of whom have over a dozen brick and
mortar locations, is a testament to the power of our home delivery model,"
said CEO Brady Cobb. "With less capital expenditure, One Plant's
efficiently scaled operations cut right to the bottom line. We are excited
about opening up new strategically located stores that will serve as both
retail dispensaries and prime delivery hubs to boost sales and EBITDA
growth."
By
the end of October 2019, One Plant is expected to open its first two (2) retail
stores in Boynton Beach and Jacksonville Beach, respectively, with four (4)
more locations anticipated for 2019.
Having
just obtained Good Agricultural Practices-Farm (GAP) and Good Manufacturing
Processing (GMP) approvals for its state-of-the-art cannabis cultivation
facility in Ruskin, Florida, One Plant is positioned to become one of the
United States' leading cannabis farms and distribution centers.
Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) one of the largest fully
integrated operators in the global medical cannabis industry with licenses
across the US and EU, announced the addition of four new
dispensaries with openings in Maryland, Delaware and Florida.
Columbia
Care’s facility in Chevy Chase represents the Company’s first dispensary in
Maryland, a state with more than 100,000 registered patients and a market
projected to reach sales in excess of $200 million by year end 2019. The
facility’s proximity to Washington, D.C., Delaware, Virginia and Pennsylvania,
all markets where Columbia Care operates, allows it to serve as one of the
cornerstones for the Company’s mid-Atlantic strategy.
Columbia
Care also opened its second dispensary in Delaware, located in Wilmington. With
approximately 9,000 patients expected to be registered in the state’s medical
program in 2019, Delaware lawmakers are expected to introduce adult use
legislation in 2020, which could significantly increase patient access as well
as the size of the total addressable market.
Finally,
the Company has added two more dispensaries in Florida with the opening of its
Sarasota and Jacksonville facilities, bringing the total number of dispensaries
open in the state to three. With over 375,000 registered patients, Florida
remains one of the largest medical cannabis markets in the world.
“No
debt and a significant cash position gives Columbia Care one of the strongest
balance sheets in the industry with access to the growth capital required to
fund our 2019 strategic plan to operationalize all of our existing licenses,”
said Nicholas Vita, chief executive officer of Columbia Care. “We are proud to
execute on the plan we previously described to our investors, and by leveraging
this strong foundation, we look forward to reaping the benefits of having one
of the largest organically developed national cannabis platforms in the US.
Opening these four additional dispensaries in key markets across the country
represents significant progress and points to an accelerated pace of activity
as we near the completion of this transformational year.”
The
Company will offer the CNC Card, the nation’s first legal credit card for
cannabis purchases, at each of these new locations. In addition, subject to
regulatory approval, the company also intends to offer its proprietary home
delivery service, “CC@Home,” which, together with the CNC Card, is designed to
provide a convenient and comfortable guest experience as well as improved
access to high-quality cannabis products capable of addressing a range of unmet
health and wellness needs.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas Investorideas.com is a recognized news source
publishing third party news, research and original financial content. Learn
about investing in stocks and sector trends with our news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change , Exploring Mining
the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...